DESIGN AND SYNTHESIS OF PRODRUGS OF ANTICANCER DRUGS FOR IMMUNOSPECIFIC ACTIVATION BY MONOCLONAL ANTIBODY-ENZYME CONJUGATES

被引:0
|
作者
VRUDHULA, VM [1 ]
机构
[1] BRISTOL MYERS SQUIBB,PHARMACEUT RES INST,SEATTLE,WA 98121
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1993年 / 206卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:32 / AGFD
相关论文
共 50 条
  • [31] Mathematical and experimental analysis of localization of anti-tumour antibody-enzyme conjugates
    Jackson, TL
    Lubkin, SR
    Siemers, NO
    Kerr, DE
    Senter, PD
    Murray, JD
    BRITISH JOURNAL OF CANCER, 1999, 80 (11) : 1747 - 1753
  • [32] Comparison of recombinant and synthetically formed monoclonal antibody-β-lactamase conjugates for anticancer prodrug activation
    Kerr, DE
    Vrudhula, VM
    Svensson, HP
    Siemers, NO
    Senter, PD
    BIOCONJUGATE CHEMISTRY, 1999, 10 (06) : 1084 - 1089
  • [33] Liposome-mediated targeting of enzymes to cancer cells for site-specific activation of prodrugs: Comparison with the corresponding antibody-enzyme conjugate
    Fonseca, MJ
    Jagtenberg, JC
    Haisma, HJ
    Storm, G
    PHARMACEUTICAL RESEARCH, 2003, 20 (03) : 423 - 428
  • [34] S9.6 Antibody-Enzyme Conjugates for the Detection of DNA-RNA Hybrids
    Wei, Elena
    Bou-Nader, Charles
    Perry, Megan L.
    Fattah, Rasem
    Zhang, Jinwei
    Leppla, Stephen H.
    Bothra, Ankur
    BIOCONJUGATE CHEMISTRY, 2023, 34 (05) : 834 - 844
  • [35] Liposome-Mediated Targeting of Enzymes to Cancer Cells for Site-Specific Activation of Prodrugs: Comparison with the Corresponding Antibody-Enzyme Conjugate
    María José Fonseca
    Joycelyn C. Jagtenberg
    Hidde J. Haisma
    Gert Storm
    Pharmaceutical Research, 2003, 20 : 423 - 428
  • [36] PLASMA-CLEARANCE OF AN ANTIBODY-ENZYME CONJUGATE IN ADEPT BY MONOCLONAL ANTI-ENZYME - ITS EFFECT ON PRODRUG ACTIVATION IN-VIVO
    ROGERS, GT
    BURKE, PJ
    SHARMA, SK
    KOODIE, R
    BODEN, JA
    BRITISH JOURNAL OF CANCER, 1995, 72 (06) : 1357 - 1363
  • [37] REGRESSIONS AND CURES OF MELANOMA XENOGRAFTS FOLLOWING TREATMENT WITH MONOCLONAL-ANTIBODY BETA-LACTAMASE CONJUGATES IN COMBINATION WITH ANTICANCER PRODRUGS
    KERR, DE
    SCHREIBER, GJ
    VRUDHULA, VM
    SVENSSON, HP
    HELLSTROM, I
    HELLSTROM, KE
    SENTER, PD
    CANCER RESEARCH, 1995, 55 (16) : 3558 - 3563
  • [38] Design, synthesis and biological evaluation of quinazoline-phosphoramidate mustard conjugates as anticancer drugs
    Lin, Songwen
    Li, Yingbo
    Zheng, Yufen
    Luo, Laichun
    Sun, Qi
    Ge, Zemei
    Cheng, Tieming
    Li, Runtao
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 127 : 442 - 458
  • [39] Synthesis and enzyme-specific activation of carbohydrate-geldanamycin conjugates with potent anticancer activity
    Cheng, H
    Cao, XH
    Xian, M
    Fang, LY
    Cai, TB
    Ji, JJ
    Tunac, JB
    Sun, DX
    Wang, PG
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (02) : 645 - 652
  • [40] New Materials for UHPLC Analysis of Monoclonal Antibody Drugs and Antibody-Drug Conjugates
    Wirth, Mary J.
    Huckabee, Alexis
    Yasosky, Jonathan
    LC GC NORTH AMERICA, 2016, 34 (06) : 423 - 425